De Maeyer
Barbara De Maeyer, Lillois-Witterzee BE
Patent application number | Description | Published |
---|---|---|
20140240858 | MIRROR - The invention relates to a mirror including a glass substrate covered with a silver layer, which is in turn covered with at least one paint layer, wherein the intensity ratio of the crystallographic orientations (111)/(200) within the silver layer is less than 5.0. Said mirror is characterized in that the silver layer has a correlation length (CLz) (111), as measured by X-ray diffraction using the Scherrer method (i.e., using the Scherrer equation) of greater than 27.0 nm. | 08-28-2014 |
Evy De Maeyer, Kallo BE
Patent application number | Description | Published |
---|---|---|
20160101837 | YACHT OR SHIP HAVING LIGHTING ELEMENTS ON OR IN HULL - The current invention relates to a yacht or other vessel, such as a ship, comprising a hull and superstructure wherein, at least one of the hull and the superstructure comprises cladding elements thereon or therein, wherein at least a selection of the cladding elements comprise an at least partially transparent cover and at least one light source, wherein the light source is shielded by the cover. Furthermore, the invention relates to a cladding element containing light sources, to be in use arranged on the hull of a yacht, or in swimming pools and in particular side walls and/or bottoms thereof, as well as on surrounding structures, like a pool house or paths or pavements there around, in bridges, for example on bridge decks and/or against uprights and/or stairs and/or walls, or in ornamentation of public spaces and public structures. | 04-14-2016 |
Joris De Maeyer, Turnhout BE
Patent application number | Description | Published |
---|---|---|
20110313153 | 5-HT4 INHIBITORS FOR TREATING AIRWAY DISEASES, IN PARTICULAR ASTHMA - The invention relates generally to the treatment of diseases of the respiratory system such as asthma and chronic obstructive pulmonary disease. More particularly, the present invention relates to methods of treating and preventing asthmatic airway inflammation. The treatment involves the administration of a 5-HT4 receptor antagonist to the subject in need thereof; more in particular the administration of aroylated 4-aminomethylpiperidine derivatives as defined herein. Other aspects of the invention are directed to compositions for treating or preventing respiratory disorders, including pharmaceutical compositions. | 12-22-2011 |
Joris Herman De Maeyer, Mechelen BE
Patent application number | Description | Published |
---|---|---|
20130045988 | COMBINATION THERAPY - Described herein is a combination comprising at least one 5-HT | 02-21-2013 |
Luk De Maeyer, Orsmaal-Linter BE
Luk De Maeyer, Linter-Diegem BE
Patent application number | Description | Published |
---|---|---|
20100292080 | USE OF SUCCINATE DEHYDROGENASE INHIBITORS FOR EXTENDING SHELF LIFE OF FRUITS AND VEGETABLES - The present invention relates to the use of succinate dehydrogenase Inhibitors for extending shelf life and storage stability of fruits and vegetables, to a method for extending shelf life of fruits and vegetables by applying a succinate dehydrogenase inhibitor to the crops prior to the harvest of the fruits or vegetables and to a fruit or vegetable treated with a succinate dehydrogenase Inhibitor. | 11-18-2010 |
20120258989 | USE OF SUCCINATE DEHYDROGENASE INHIBITORS FOR EXTENDING SHELF LIFE OF FRUITS AND VEGETABLES - The present invention relates to the use of succinate dehydrogenase Inhibitors for extending shelf life and storage stability of fruits and vegetables, to a method for extending shelf life of fruits and vegetables by applying a succinate dehydrogenase inhibitor to the crops prior to the harvest of the fruits or vegetables and to a fruit or vegetable treated with a succinate dehydrogenase Inhibitor. | 10-11-2012 |
Luk De Maeyer, Linter BE
Patent application number | Description | Published |
---|---|---|
20100222397 | Use of Succinate Dehydrogenase Inhibitors For Controlling Powdery Mildew Primary Infections - The present invention relates to the use of succinate dehydrogenase Inhibitors for controlling powdery mildew primary infections in crops and to a method for controlling those primary infections. | 09-02-2010 |
20130245050 | Use of N-Phenylethylpyraozole Carboxamide Derivatives or Salts Thereof for Extending Shelf Life of Fruits and Vegetables - The present invention relates to the use of N-phenylethylpyrazole carboxamide derivatives or salts thereof for extended shelf life and storage stability of fruits and vegetables, to a method for extending shelf life or fruits and vegetables by applying N-phenylethylpyrazole carboxamide derivatives or salts thereof to the crops prior to the harvest of the fruits or vegetables. | 09-19-2013 |
20140051735 | USE OF N-PHENYLETHYLPYRAZOLE CARBOXAMIDE DERIVATIVES OR SALTS THEREOF FOR CONTROLLING POWDERY MILDEW PRIMARY INFECTIONS - The present invention relates to the use of N-phenylethylpyrazole carboxamide derivatives, in particular 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid [2-(2,4-dichlorophenyl)-2-methoxy-1-methyl-ethyl]-amide for controlling powdery mildew primary infections in crops and to a method for controlling those primary infections. | 02-20-2014 |
Luk De Maeyer, Belgium BE
Patent application number | Description | Published |
---|---|---|
20150025117 | USE OF SUCCINATE DEHYDROGENASE INHIBITORS FOR CONTROLLING POWDERY MILDEW PRIMARY INFECTIONS - The present invention relates to the use of succinate dehydrogenase Inhibitors for controlling powdery mildew primary infections in crops and to a method for controlling those primary infections. | 01-22-2015 |
Marc De Maeyer, Heverlee BE
Patent application number | Description | Published |
---|---|---|
20120059028 | THIENO [2, 3-B] PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS - The present invention relates to a series of compounds having antiviral activity, more specifically HIV (Human Immunodeficiency Virus) replication inhibiting properties. The invention also relates to methods for the preparation of such compounds, as well as to novel intermediates useful in one or more steps of such syntheses. The invention also relates to pharmaceutical compositions comprising an effective amount of such compounds as active ingredients. This invention further relates to the use of such compounds as medicines or in the manufacture of a medicament useful for the treatment of animals suffering from viral infections, in particular HIV infection. This invention further relates to methods for the treatment of viral infections in animals by the administration of a therapeutic amount of such compounds, optionally combined with one or more other drugs having anti-viral activity. | 03-08-2012 |
20140296272 | THIENO [2, 3-B] PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS - The present invention relates to a series of compounds having antiviral activity, more specifically HIV (Human Immunodeficiency Virus) replication inhibiting properties. The invention also relates to methods for the preparation of such compounds, as well as to novel intermediates useful in one or more steps of such syntheses. The invention also relates to pharmaceutical compositions comprising an effective amount of such compounds as active ingredients. This invention further relates to the use of such compounds as medicines or in the manufacture of a medicament useful for the treatment of animals suffering from viral infections, in particular HIV infection. This invention further relates to methods for the treatment of viral infections in animals by the administration of a therapeutic amount of such compounds, optionally combined with one or more other drugs having anti-viral activity. | 10-02-2014 |
Marc De Maeyer, Vaalbeek BE
Patent application number | Description | Published |
---|---|---|
20120129840 | NOVEL VIRAL REPLICATION INHIBITORS - The present invention relates to a series of novel compounds having antiviral activity, more specifically HIV (Human Immunodeficiency Virus) replication inhibiting properties. The invention also relates to methods for the preparation of such compounds, as well as to novel intermediates useful in one or more steps of such syntheses. The invention also relates to pharmaceutical compositions comprising an effective amount of such compounds as active ingredients. This invention further relates to the use of such compounds as medicines or in the manufacture of a medicament useful for the treatment of animals suffering from viral infections, in particular HIV infection. This invention further relates to methods for the treatment of viral infections in animals by the administration of a therapeutical amount of such compounds, optionally combined with one or more other drugs having antiviral activity. | 05-24-2012 |
20120316161 | NOVEL ANTIVIRAL COMPOUNDS - The present invention relates to compounds of formula (A) as defined herein having antiviral activity, more specifically HIV (Human Immunodeficiency Virus) replication inhibiting properties. The invention also relates to pharmaceutical compositions comprising an effective amount of such compounds as active ingredients. This invention further relates to the use of such compounds as medicines or in the manufacture of a medicament useful for the treatment of animals suffering from viral infections, in particular HIV infection. This invention further relates to methods for the treatment of viral infections in animals by the administration of a therapeutical amount of such compounds, optionally combined with one or more other drugs having antiviral activity. | 12-13-2012 |
20130245049 | Novel Antiviral Compounds - The present invention relates to compounds of formula (A), as further defined herein, having antiviral activity, more specifically HIV (Human Immunodeficiency Virus) replication inhibiting properties. The invention also relates to pharmaceutical compositions comprising an effective amount of such compounds as active ingredients. The invention further relates to the use of such compounds, optionally combined with one or more other drugs having antiviral activity, for the treatment of animals suffering from viral infections, in particular HIV infection. | 09-19-2013 |
20150051195 | NOVEL VIRAL REPLICATION INHIBITORS - The present invention relates to a series of novel compounds having antiviral activity, more specifically HIV (Human Immunodeficiency Virus) replication inhibiting properties. The invention also relates to methods for the preparation of such compounds, as well as to novel intermediates useful in one or more steps of such syntheses. The invention also relates to pharmaceutical compositions comprising an effective amount of such compounds as active ingredients. This invention further relates to the use of such compounds as medicines or in the manufacture of a medicament useful for the treatment of animals suffering from viral infections, in particular HIV infection. This invention further relates to methods for the treatment of viral infections in animals by the administration of a therapeutical amount of such compounds, optionally combined with one or more other drugs having antiviral activity. | 02-19-2015 |
20150336965 | NOVEL ANTIVIRAL COMPOUNDS - The present invention relates to compounds of formula (A), as further defined herein, having antiviral activity, more specifically HIV (Human Immunodeficiency Virus) replication inhibiting properties. The invention also relates to pharmaceutical compositions comprising an effective amount of such compounds as active ingredients. The invention further relates to the use of such compounds, optionally combined with one or more other drugs having antiviral activity, for the treatment of animals suffering from viral infections, in particular HIV infection. | 11-26-2015 |